HC Wainwright reissued their buy rating on shares of Evaxion Biotech A/S (NASDAQ:EVAX – Free Report) in a report published on Wednesday, MarketBeat reports. HC Wainwright currently has a $14.00 price target on the stock. HC Wainwright also issued estimates for Evaxion Biotech A/S’s FY2024 earnings at ($0.01) EPS, FY2025 earnings at $0.13 EPS, FY2026 […]